RxDoctor Payments Data

Karin Pardue, MD

Family Medicine · Century, FLNPI 1972697308

Payments from drug & device makers

$432in general payments, 2019–2025

Across 26 payments — averaging $16.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$99
  • Otsuka America Pharmaceutical, Inc.$64
  • Avanir Pharmaceuticals, Inc.$59
  • Novo Nordisk$45
  • AstraZeneca$28
  • Sunovion Pharmaceuticals Inc.$28
  • plus $110 from 6 others

What the payments were for

  • Food & beverage$432100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$432 in reported general payments places this provider in the 45th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$18,416
Medicare patients
61
Services billed
174

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Enbrel SureclickEtanercept16$119,292
OzempicSemaglutide48$61,689
EliquisApixaban87$41,520
TrulicityDulaglutide37$37,898
MounjaroTirzepatide35$36,581
FarxigaDapagliflozin Propanediol43$19,605
JardianceEmpagliflozin17$12,813
JanuviaSitagliptin Phosphate14$12,635
Bydureon BciseExenatide Microspheres12$9,717
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen386$9,307
XareltoRivaroxaban13$7,451
MyrbetriqMirabegron16$7,406
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$5,962
Tresiba Flextouch U-100Insulin Degludec14$5,460
Levetiracetam108$3,922

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$16$74,47972 claims
Novo NordiskOzempic$45$61,68948 claims
PfizerEliquis$21$41,52087 claims
AstraZenecaFarxiga$28$19,60543 claims
GSKTrelegy Ellipta$13$5,96211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Century

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →